Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae
- PMID: 16966400
- PMCID: PMC1635193
- DOI: 10.1128/AAC.00747-06
Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae
Abstract
Posaconazole and itraconazole were more potent inhibitors of ergosterol synthesis, in both intact cells and cell extracts from Absidia corymbifera and Rhizopus oryzae, than voriconazole and fluconazole. Similarly, expression of CYP51 from R. oryzae in Saccharomyces cerevisiae significantly increased resistance to fluconazole and voriconazole but not to posaconazole and itraconazole.
Figures
References
-
- Ballard, S. A., S. L. Kelly, S. W. Ellis, and P. F. Troke. 1990. Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole. J. Med. Vet. Mycol. 28:327-334. - PubMed
-
- Calabrese, D., J. Bille, and D. Sanglard. 2000. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 146:2743-2754. - PubMed
-
- Clinical and Laboratory Standards Institute. 2002. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard M38-A. National Committee for Laboratory Standards, Wayne, Pa.
-
- Goldman, G. H., M. E. da Silva Ferreiraqq, Edos Reis Marques, M. Savoldi, D. Perlin, S. Park, P. C. Godoy Martinez, M. H. Goldman, and A. L. Colombo. 2004. Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV-infected patients in Brazil. Diagn. Microbiol. Infect. Dis. 501:25-32. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
